0

Glyburide (Glibenclamide)

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP10238218-B
CAS10238-21-8
Structure
MDL NumberMFCD00056625
Molecular Weight494.00
EC Number233-570-6
InChI KeyZNNLBTZKUZBEKO-UHFFFAOYSA-N
DescriptionPharmaceutical Secondary Standard; Certified Reference Material
Formneat; traceable to PhEur G0325000; traceable to USP 1295505
Gradecertified reference material; pharmaceutical secondary standard
Size1G
1

Adverse Cardiovascular Events During Treatment With Glyburide (Glibenclamide) or Gliclazide in a High-Risk Population

D N Juurlink, T Gomes, B R Shah, M M Mamdani

Diabet Med. 2012 Dec;29(12):1524-8.

PMID: 22913620

1

Hypoglycemic Activity of Glyburide (Glibenclamide) Metabolites in Humans

T Rydberg, A Jönsson, M Røder, A Melander

Diabetes Care. 1994 Sep;17(9):1026-30.

PMID: 7988301

1

Sulfonylurea Derivatives and Cancer, Friend or Foe?

Anne M Hendriks, Dennis Schrijnders, Nanne Kleefstra, Elisabeth G E de Vries, Henk J G Bilo, Mathilde Jalving, Gijs W D Landman

Eur J Pharmacol. 2019 Oct 15;861:172598.

PMID: 31408647

1

The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared With Modified-Release Gliclazide

Kristin K Clemens, Eric McArthur, Stephanie N Dixon, Jamie L Fleet, Irene Hramiak, Amit X Garg

Can J Diabetes. 2015 Aug;39(4):308-16.

PMID: 25840942

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode